Mechanism
GI lipase + intestinal alpha-glucosidase
Assets acting on this target.
- Class
- Modified-release fixed-dose combination of lipase inhibitor and alpha-glucosidase inhibitor
- Notes
- audit finding #2272 (material); source: https://clinicaltrials.gov/api/v2/studies/NCT06993428